Studies suggest the prevalence of deficiency in the UK is one in 10 people aged 75 and over, one in 20 aged 65-74, and lower in younger age groups except for vegans, where prevalence is around 11%
With the right integrative approach, this stage of life can become an opportunity for deep metabolic healing, nervous system regulation, and renewed connection to the body
Talk to your doctor about the risks and possible benefits of taking any supplements
Microcirculation 25 (7), e12492
Type: Solution for Injection (I M / I V.)
Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories: post hoc analysis of a randomized, double-blind, placebo-controlled, multinational trial